Clinical Study
Evaluation of RANKL/OPG Serum Concentration Ratio as a New Biomarker for Coronary Artery Calcification: A Pilot Study
Table 1
Demographic data, laboratory tests, and traditional cardiovascular risk factors of patients.
| | Age (year) | | | Female/male ratio | 0.35 | | Mean BMI | | | Laboratory test | | | Calcium (ng/dL) | | | Phosphorous (ng/dL) | | | HDL cholesterol (mg/dL) | | | LDL cholesterol (mg/dL) | | | Total cholesterol (mg/dL) | | | FBS (mg/dL) | 103.28 ± 30 | | Mean concentration of RANKL (pg/mL) (CV) | (0.16) | | Mean concentration of OPG (pg/mL) (CV) | (0.13) | | RANKL/OPG ratio (CV) | (0.12) | | Total calcification of coronary vessels (agatson) | | | Calcification in coronary LAD (agatson) | | | Calcification in coronary RCA (agatson) | | | Calcification in coronary CX (agatson) | | | Calcification in coronary LM (agatson) | | | Traditional cardiovascular risk factors | | | Hypertension (%) | 54.84 | | Dyslipidemia (%) | 73 | | Positive family history (%) | 46 | | Diabetes (%) | 17 | | Current smoking (%) | 13 |
|
|
